Price Assessment for INJ: INJ Maintains Crucial Support at $13; Potential Uptrend to $15 on the Horizon?
The cryptocurrency market has been on a rollercoaster ride, and Injective (INJ) is no exception. Despite a few catalysts that have anchored INJ's resilience, including the EVM testnet launch and integrations with Google Cloud and Deutsche Telekom, which triggered a ~15% rally, the current price action shows the token being confined within an ascending triangle.
According to recent expert forecasts, it is unlikely that Injective (INJ) will break above $20 this week. Analysts and price predictions generally project INJ prices to remain below $20 in the near term, with most forecasts placing the price in the $13–$17 range throughout 2025.
Changelly projects that in August 2025, INJ may drop to a minimum of $13.51, with a peak around $16.95. CoinPriceForecast anticipates INJ reaching $15 by the end of 2025 and $20 only by mid-2026, indicating $20 is a longer-term target rather than imminent. Coin Edition’s August 2025 outlook points to a potential high near $19.80 for the entire year, with average prices closer to $15.50. They note a bullish daily Supertrend but also mention downside risk near $14.00, consistent with current consolidation rather than immediate breakout past $20.
Ainvest’s recent technical analysis suggests a bullish setup if INJ holds support around $12.20 and breaks above $16.00, which then could lead to moves targeting $25. However, this scenario depends on a bounce and breakout above $16, which has not yet occurred.
Regarding the potential bullish crossover of moving averages, while a crossover can be a positive signal, current prices and forecasts do not support a rapid surge past $20 within this week. Technical indicators like the Relative Strength Index (RSI) are neutral, indicating no strong momentum yet.
However, there are signs that the price could maintain an ascending consolidation and reach the resistance threshold between $15.79 and $16.25. The recent rebound before hitting the ascending support suggests that the bulls hold significant dominance. The levels of the Chainkin Money Flow (CMF) are printing consecutive higher highs and lows, suggesting a rebound could be on the horizon.
The MACD is showing a drop in the selling pressure, and a daily close above the current range with a decent rise in volume could push the INJ price above $20 this week. The price action shows signs of stabilization, with the INJ price potentially moving toward the $14.80-$15.20 range.
Investor interest and developer activity have been driven by the EVM testnet launch and integrations, but no major updates have emerged in the last 48 hours for the Injective project. Institutional staking provider BitGo's addition to the Injective validator set bolstered network security.
In conclusion, while a bullish crossover and consolidation near $13.20 may lay groundwork for longer-term gains, market consensus and technical factors suggest that breaking above $20 this week is improbable. Prices around $14–$17 appear more realistic short-term targets, with $20+ expected only later in 2025 or in 2026.
Trading INJ in the short term may be focused on opportunities within the $14–$17 range, given current price projections and market consensus. Stronger finance-backed technological innovations such as the EVM testnet launch and integrations may contribute to longer-term investing prospects, potentially pushing the price towards $20+ in 2025 or 2026.
